Critical Diagnostics Release: Cardiovascular Disease Marker Company Achieves Two Major Milestones: Issuance of a U.S. Patent for ST2 Testing in Symptomatic Patients and Sales of ST2 Assay in Europe

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics today announced the issuance of patent number 7,998,683 titled Predicting Mortality and Detecting Severe Disease.

MORE ON THIS TOPIC